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Reduction in Urinary Arsenic with Bottled-water
Intervention
Arun B. Josyula1, Hannah McClellen1, Tracy A. Hysong1,
Margaret Kurzius-Spencer1, Gerald S. Poplin1, Stefan Stürup2,
and Jefferey L. Burgess1
1Environmental

and Occupational Health, Mel and Enid Zuckerman College of Public
Health, University of Arizona, Tucson, AZ 85719, USA and 2Dartmouth Trace Element
Analysis Core Facility, Dartmouth College, Hanover, NH, USA
ABSTRACT
The study was conducted to measure the effectiveness of providing bottled water in reducing arsenic
exposure. Urine, tap-water and toenail samples were collected from non-smoking adults residing in Ajo
(n=40) and Tucson (n=33), Arizona, USA. The Ajo subjects were provided bottled water for 12 months
prior to re-sampling. The mean total arsenic (µg/L) in tap-water was 20.3±3.7 in Ajo and 4.0±2.3 in
Tucson. Baseline urinary total inorganic arsenic (µg/L) was significantly higher among the Ajo subjects
(n=40, 29.1±20.4) than among the Tucson subjects (n=32, 11.0±12.0, p<0.001), as was creatinine-adjusted
urinary total inorganic arsenic (µg/g) (35.5±25.2 vs 13.2±9.3, p<0.001). Baseline concentrations of
arsenic (µg/g) in toenails were also higher among the Ajo subjects (0.51±0.72) than among the Tucson
subjects (0.17±0.21) (p<0.001). After the intervention, the mean urinary total inorganic arsenic in
Ajo (n=36) dropped by 21%, from 29.4±21.1 to 23.2±23.2 (p=0.026). The creatinine-adjusted urinary
total inorganic arsenic and toenail arsenic levels did not differ significantly with the intervention.
Provision of arsenic-free bottled water resulted in a modest reduction in urinary total inorganic arsenic.
Key words: Arsenic; Drinking-water; Bottled water; United States
INTRODUCTION
Exposure of humans to inorganic arsenic is associated
with an increased risk of lung, bladder, skin and other cancers (1,2). Although inorganic arsenic is found throughout the environment, drinking-water constitutes the most
significant source of exposure for most populations.
Moschandreas et al. have estimated the contribution of
drinking-water to the overall daily arsenic exposure to be
35%. Exposure of inorganic arsenic through ingestion
(food and water) also depends on certain demographic
characteristics, such as age, race/ethnicity, and poverty
level (3).
Correspondence and reprint requests should be addressed to:
Dr. Jefferey L. Burgess
Associate Professor
Environmental and Community Health
Mel and Enid Zuckerman College of Public Health
University of Arizona
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On 22 January 2001, the U.S. Environmental Protection
Agency lowered the maximum contaminant level (MCL)
allowable for arsenic in drinking-water in the public
water systems, from 50 µg/L to 10 µg/L, beginning 23
January 2006 (4). Although this will reduce arsenic exposure of drinking-water from the public water systems
that currently do not meet these standards, it will require
significant expenditure for modifications to these systems.
In addition, exposure at the new standard of the U.S.
Environmental Protection Agency may still confer health
risks. The costs involved in reduction of arsenic may not
be a reasonable option for small municipal water systems
or households using personal well-water. Hence, arsenicfree bottled water may be a safe alternative in these
settings.
In this study, we compared baseline urinary and toenail
arsenic in Ajo and Tucson, Arizona, USA and evaluated
the impact of providing arsenic-free bottled water, for
one year, on biomarkers of arsenic exposure in Ajo. The
primary hypothesis of the study was that provision of
bottled-water supplies would reduce arsenic exposure
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as measured by total inorganic arsenic species in urine
and concentrations of arsenic in toenails.
MATERIALS AND METHODS
Study area and selection of households
Census blocks within census tracts were initially selected
at random. Based on a probability proportional to size
(PPS) sampling protocol (5), our goal was to recruit a
maximum of five households per census block. Our inclusion criteria required at least three years of continuous
residence in Ajo at the time of recruitment, age over 18
years, exclusive use of tap-water for drinking and food
preparation, and no current smoking. Given our restrictive inclusion criteria, we had difficulty in recruiting the
sufficient number of subjects using the PPS protocol in
Ajo. Subsequently, we resorted to a census of the entire
community. In Tucson, the five census tracts that most
closely resembled the Ajo population in age distribution
(median age= 52 years) and percentage of Hispanic residents (38%) in the 2000 census were selected. Two of
the five census tracts were randomly selected, and census
blocks and households in these blocks were randomized.
Again, we recruited up to five households per block.
The majority of households in both the communities that
did not meet the inclusion criteria reported extensive
use of bottled water. Recruitment of households took
place during June-August 2002 in Ajo and during July
2002_August 2003 in Tucson. Up to two eligible subjects
from each household were recruited.
Sample collection
At the time of home-visit, participants completed a questionnaire adapted from the National Human Exposure
Assessment Survey regarding residential and occupational history, health status, smoking status, and source
of water. Water samples were collected using two sterile
50-cc polypropylene conical vials. Cold water
from kitchen faucet of participants was allowed to
run for one minute before collection began. The water
samples were stored at 4 ºC until analysis of arsenic.
First-morning void urine samples were collected on
the day of appointment for sample collection from each
subject. Two sterile 120-cc screw-top containers were
provided for the collection of urine. These containers
had previously been tested to ensure that they did not
impart any measurable arsenic to stored liquid. Urine
samples were processed within two hours of collection
using the following protocol. The urine sample was repeatedly inverted and swirled to re-suspend the cells
into solution, and approximately 200 mL was equally
aliquoted into four 50-mL vials and spun at 2,400 rpm

for 12 minutes at room temperature. The supernatant
was then transferred to two 15-mL conical vials, temporarily stored at -20 °C, later transported to Tucson, and
stored at -70 °C prior to analysis for arsenic. On the
appointment day, subjects were provided toenail clippers
and small paper envelopes and were instructed to cut
their big toenails and other toenails of both feet after
taking their morning bath and to keep the toenail samples in the envelope for collection by the field team.
Analysis of arsenic: urine and water
An HPLC-ICP-MS speciation method was modified
for the measurement of arsenic (6). The HPLC system
consisted of an Agilent 1100 HPLC (Agilent Technologies, Inc., Palo Alto, CA) with a reverse-phase C18
column (Prodigy 3µ ODS-3, 150x4.60 mm; Phenomenex, Torrance, CA). The mobile phase (pH 5.85) contained 4.7 mM tetrabutylammonium hydroxide, 2 mM
malonic acid, and 4% (v/v) methanol at a flow rate of
1.2 mL per minute. Column temperature was maintained
at 50 °C. An Agilent 7500a ICP MS with a Babington
nebulizer was used as the detector. The operating parameters were as follows: Rf power_1,500 W; plasma gas
flow_15 L per minute; carrier flow_1.2 L per minute;
and arsenic was measured at m/z 75. For total arsenic,
an ASX500 autosampler (CETAC Technologies, Omaha,
NE) was used for introducing the samples into the Agilent 7500a ICP-MS. The operating parameters were as
follows: Rf power_1,500 W; plasma gas flow_15 L per
minute; and carrier flow_1.2 L per minute. The acquisition parameters were arsenic measured at m/z 75, terbium (IS) measured at m/z 159, points per peak were 3,
dwell time for arsenic was 1.5 seconds, and the dwell time
for terbium was 1.5 seconds. Differential analysis of unstable MMA III and DMA III metabolites was not
possible. The sensitivity limits for arsenic species was
pre-determined to range from 0.04 to 0.08 µg/L.
For this analysis, total inorganic arsenic was defined
as the sum of As3+, As5+, and the methylated metabolites
monomethylarsonic acid (MMA) and dimethylarsenic
acid (DMA). Urine or water arsenic species with levels
lower than the detectable limits were assigned values
of one-half the limit of detection for that particular arsenic species. The creatinine levels were estimated in urine
samples using the Jaffe reaction method in a microplate
format (Quidel Inc., San Diego, CA). Urinary arsenic
concentration was adjusted for creatinine by expressing
its level as a ratio with creatinine (µg/g creatinine). In
accordance with the recommendations of the World
Health Organization (WHO), urine samples with inadequate (<30 mg/dL; n=9) or excessive (>300 mg/dL;
n=1) concentrations of creatinine were not included in
analyses (7).
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Analysis of arsenic: toenails
As part of a cooperative project involving the University
of Arizona and Dartmouth College, toenails were sent
to the Dartmouth College for analysis of arsenic. Each
toenail sample was washed with acetone, Triton X-100,
and water to remove external contaminants. Afterwards,
the complete sample was weighed into a Teflon vial, one
mL of concentrated HNO3 was added and capped, and
the sample was digested under pressure at 30 ºC in a
microwave oven. The resulting solution was added to
4 mL of water and stored at 5 ºC until analysis. For arsenic analysis, this solution was diluted an additional four
times with water and was analyzed using an Agilent
7500c ICP-MS instrument with an Octapole reaction
cell pressurized with helium gas to remove potential
interference from ArCl on m/z= 75, the mass of the arsenic ion. The detection limit was 0.005 µg/g.
Intervention: water delivery
Bottled water from Sparkletts® was tested to determine
levels of arsenic using methods similar to those described
above. A water-cooler with a regular supply of bottled
water was provided to each participating household from
Ajo for one year. The participants were instructed to use
it for drinking, cooking, and preparation of all foods for
the entire year. At the end of the year, the study team
would return to collect another urine sample. Water was
delivered twice a month or according to the needs of
participants. The participants were telephoned over the
course of the year to ensure that they were using bottled
water for cooking and drinking and that enough was
being delivered for their needs. Samples of urine and
bottled water were collected at the end of one year using
the methods described above.
Statistical analysis
Data were analyzed using SPSS 12.0 (Chicago, IL).
Population characteristics were compared using t-tests
and chi-square analysis. The Mann-Whitney U-test was
used for evaluating the differences at baseline in total
and speciated urinary arsenic measures between Ajo and
Tucson. Pre- and post-intervention-speciated urinary
arsenic and toenail arsenic levels among the Ajo participants were compared using Wilcoxon signed rank test
for matched pairs. Spearman's rank correlation coefficient was used for evaluating correlations between levels
of arsenic in water, urine, and toenails.
The Institutional Review Board at the University of
Arizona approved the study.
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RESULTS
Forty subjects from 33 households in Ajo and 33 subjects
from 30 households in Tucson, who met eligibility requirements, were enrolled in the study. Their demographic characteristics are presented in Table 1. There were
no significant differences between the Ajo and the Tucson
study subjects in terms of gender, age, age distribution,
race/ethnicity, past smoking, pre-existing illness, or the
Table 1. Characteristics of participants in Ajo and
Tucson
Ajo (n=40) Tucson (n=33)
Characteristics
No.
%
No.
%
Female
25
63
21
64
Age (mean±SD)
61.8±15.8
64.7±14.5
Age-group (years)
<60
16
40
13
39
60-80
18
45
15
46
>80
6
15
5
15
Race/ethnicity
White/non-Hispanic
23
58
23
70
Hispanic
16
40
10
30
Other
1
2
0
0
Past smoker
18
45
12
40
Pre-existing illness
Ulcer
2
5
2
6
Asthma
14
35
16
48
Diabetes
8
20
5
15
Education
Less than high school 7
18
4
12
High school graduate 13
32
9
27
College and beyond
20
50
20
61
highest level of education attained. The participants were
predominantly female, aged over 60 years, with at least
a high school education. Approximately, one-third of
them from each town were Hispanic. During the intervention, four subjects in Ajo dropped out of the study.
Baseline arsenic in water and urine
At baseline, no subjects used bottled water either for
cooking or for drinking. Table 2 shows that the mean
total arsenic in tap-water in Ajo was 20.3 µg/L (range
10.8-27.6 µg/L) and was significantly higher than that
in Tucson (mean 4.02 µg/L, range 0.8-9.5 µg/L, p<0.001).
Arsenate (As5+) was the major contributor to total inorganic arsenic in water in both the towns, comprising
approximately 75% and 95% of the total in Tucson and
Ajo respectively. The baseline concentrations of total
urinary arsenic and total urinary inorganic arsenic were
significantly higher in Ajo than in Tucson (p<0.001 for
both). When the analysis was restricted to individuals
who did not consume arsenic-containing food items,
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including seafood or mushrooms, urinary arsenic concentration was still significantly lower in Tucson than
in Ajo. For urinary As3+, As5+, and MMA, 10%, 36%,
and 8% of the samples respectively were below the
limit of detection. The ratio of either MMA or DMA over
the sum of As3+ and As5+ and the ratio of DMA/MMA
did not differ significantly between the towns. Fortythree baseline urine samples were determined to be valid

DMA/MMA ratio. No significant changes in the relative
levels of MMA/(As3++As5+) or DMA/(As3++As5+) were
observed with the bottled-water intervention.
When these comparisons were restricted to those 29
subjects who reported using bottled water for cooking,
drinking, and beverage preparation, the total inorganic
arsenic levels were significantly reduced with the inter-

Table 2. Characteristics of arsenic species in subjects from Tucson and Ajo at baseline
Arsenic species or ratio

Ajo
Mean±SD

Tucson
Mean±SD

Tap-water (n)
Total arsenic (µg/L)
Urine (n)
Total arsenic (µg/L)
Total inorganic arsenic (µg/L)
Creatinine (µg/dL)*
Total inorganic arsenic/creatinine (µg/g)*
As3+ (µg/L)
As5+ (µg/L)
MMA (µg/L)
DMA (µg/L)
MMA/(As3++As5+)
DMA/(As3++As5+)
DMA/MMA
Toenail (n)
Arsenic (µg/g)

33
20.3±3.7
40
28.3±18.6
29.1±20.4
108.2±57.4
30.6±13.2
6.8±8.8
2.0±2.6
2.9±3.7
17.5±12.5
0.7±0.6
5.1±5.9
13.1±29.0
38
0.51±0.72

29
4.0±2.3
32
14.0±13.5
11.0±12.0
87.5±50.8
13.7±9.6
4.3±8.6
0.2±0.5
1.0±1.1
5.5±4.4
1.9±3.2
10.8±14.1
14.4±23.1
33
0.17±0.21

*Valid

p value
<0.001
<0.001
<0.001
0.254
<0.001
0.011
< 0.001
< 0.001
< 0.001
0.461
0.225
0.511
0.001

values n=14 for Ajo and n=29 for Tucson; SD=Standard deviation

for adjustment of creatinine, based on the recommendations of WHO for concentrations of creatinine (Ajo, n=14;
Tucson, n=29). Twenty samples from Ajo were not available for analysis of creatinine. The population characteristics of the subset of individuals with valid measurements of creatinine were compared with the rest in each
group, but no significant differences were observed.
Baseline creatinine-adjusted total urinary inorganic
arsenic was significantly higher in Ajo than in Tucson
(p<0.001).
Water intervention in Ajo and changes in speciated
urinary arsenic
Concentrations of arsenic in bottled water were all below
the limit of detection (~0.1 µg/L). Comparison of total
inorganic urinary arsenic concentrations at baseline and
follow-up revealed a 21% reduction associated with the
intervention (from 29.4 to 23.2 µg/L, p<0.026) (Table 3).
There was no significant difference in creatinine-adjusted
urinary total inorganic arsenic between the pre- and the
post-intervention (n=11). Drinking-water intervention
was associated with a significant reduction in DMA and

vention (31.0±22.9 vs 21.6±20.6 µg/L, p=0.013). However, creatinine-adjusted urinary inorganic arsenic was
not significantly reduced with the intervention (27.4±8.0
v. 27.3±24.4 µg/g, p=0.735). The relative proportions
of MMA/(As3++As5+) or DMA/(As3++As5+) did not vary
significantly with the intervention.
Changes in toenail arsenic
Toenails were collected, on average, within one week of
initial interview. At baseline, the toenail arsenic levels
were significantly higher in Ajo than in Tucson (Table 2).
When data from both the towns were combined, there
was a significant positive correlation between toenail
arsenic and total urinary inorganic arsenic (ρs=0.344,
p=0.004). There was a non-significant decline of approximately 47% between the pre- and the post-intervention
toenail arsenic level (p<0.061) (Table 3). For the 28
subjects who provided toenail samples and reported
exclusive use of bottled water for drinking and food preparation during the intervention period, a significant reduction in concentrations of arsenic in toenails was
observed (0.53±0.75 µg/g vs 0.26±0.21 µg/g, p=0.032).
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DISCUSSION
As expected, we found significantly increased total arsenic and total inorganic urinary arsenic, along with significantly increased concentrations of arsenic in toenail in
Ajo compared to Tucson. This finding was consistent
with a higher exposure to arsenic in Ajo through tap-water.
Arsenic-free bottled-water intervention in Ajo significantly reduced total inorganic arsenic in urine, although
the change was not observed with adjustment of creatinine, and the decline in toenail arsenic was only significant when the analysis was restricted to those subjects
who reported exclusive use of bottled water. These
findings suggest that, over a one-year period, provision
of bottled water had limited effectiveness in reducing
arsenic exposure in this study community.

2.4 µg/kg body-weight of arsenic exposure (~37% of
which is inorganic), depending on the source and quantity. Similarly, arsenic exposure from water could range
from as low as 0.1 to as high as 31 µg/kg of body-weight,
depending on locality of the water source. Quality of soil
and environmental air contributes a lesser extent to daily
arsenic exposure (8). Although we could not quantify all
these factors in our analysis, drinking-water intervention
alone may not sufficiently reduce daily arsenic exposure,
especially when the baseline daily exposure contribution
from water is not high.
Very little published information is available on the
effectiveness of provision of bottled water in reducing
arsenic exposure. Hopenhayn-Rich et al. studied the
effects of drinking-water intervention in individuals with

Table 3. Arsenic species in Ajo before and after bottled-water intervention
Arsenic species or ratio

Pre-intervention

Post-intervention

36
28.3±18.9
29.4±21.1
109.2±58.3
27.8±10.1
6.4±9.0
2.1±2.7
3.0±3.8
17.9±12.7
0.7±0.6
5.3±6.1
8.3±5.2
34
0.49±0.68

36
22.4±21.4
23.2±23.2
107.9±86.2
31.8±23.7
10.3±20.8
1.7±1.9
2.0±1.8
9.1±8.1
1.2±3.5
3.8±5.2
5.0±3.3
34
0.26±0.19

Urine (n)
Total arsenic (µg/L)
Total inorganic arsenic (µg/L)
Creatinine (µg/dL)*
Total inorganic arsenic/creatinine (µg/g)*
As3+ (µg/L)
As5+ (µg/L)
MMA (µg/L)
DMA (µg/L)
MMA/(As3++As5+)
DMA/(As3++As5+)
DMA/MMA
Toenail (n)
Arsenic (µg/g)

p value
0.035
0.026
0.424
0.79
0.730
0.943
0.091
<0.001
0.814
0.114
0.001
0.061

*Number

of samples with available valid creatinine levels=11
As=Arsenic; DMA=Dimethylarsenic acid; MMA=Monomethylarsonic acid
Although the total urinary arsenic levels in Ajo were
reduced significantly with the bottled-water intervention,
the post-intervention urinary arsenic levels were still far
above those found in Tucson. This finding denotes that
some degree of arsenic exposure continued to occur
among the Ajo subjects despite the drinking-water intervention. Although 29 of the 36 subjects reported exclusive use of bottled water for cooking and drinking, the
intermittent use of tap-water for cooking and preparation
of beverages by the study subjects, and exposure to arsenic through food or other sources, may help explain the
limited effect observed with the intervention.
Food and water are the major primary sources of nonoccupational daily arsenic exposure. According to the
toxicological profile of the U.S. Department of Health
and Human Services for arsenic, food contributes up to

high arsenic exposure (>600 µg/L) (9). In the HopenhaynRich study, replacement drinking-water, which contained
arsenic at approximately 45 µg/L, was provided for two
months. The mean urinary total inorganic arsenic level
before and after drinking-water intervention was 636
µg/L and 166 µg/L respectively. Similar to our study,
the authors found a reduction in both DMA but also
found a reduction in MMA and inorganic arsenic. In
contrast to our study, the DMA/MMA ratio increased
following the intervention.
Baseline measures of both MMA and DMA were significantly higher in individuals in Ajo than in Tucson,
but the ratio of either MMA/(As3++As 5+) or DMA/
(As3++As5+) as respective indicators of primary and
secondary arsenic methylation activity in the liver, did
not differ significantly between the towns. However, the
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DMA/MMA ratio was significantly reduced with the intervention. Approximately, 70-85% of the ingested arsenic is excreted through the kidney with DMA being the
principal metabolite. As reported in other studies, DMA
is the principal arsenic metabolite following low level
of arsenic exposure, trailed by MMA and inorganic forms
(9,10). Due to increased solubility and more rapid rate
of excretion, methylated forms (MMA and DMA) are
generally thought to be less acutely toxic than inorganic
forms. However, in more recent reports, Aposhian et al.
and Wildfang et al. suggested that arsenic methylation
may not be the universal detoxification mechanism for
arsenic as once thought (11,12). Other studies have
suggested that arsenic methylation may potentiate its
toxicity (13,14). Also, contrary to an earlier belief that
inorganic arsenite is the most toxic form of arsenic,
Petrick et al. described relative toxicity profiles in human liver cells in the following order: MMA (III) >>>
As3+ >> As5+ >> MMA (V)=DMA (V) (15).
Our study had several limitations. Estimates of total
arsenic exposure through diet, water, dust, and air were
not available. Although increased exposure to environmental arsenic near copper-smelting towns has been welldocumented (16), we were unable to assess the contribution of exposures at work or away from home. Another
documented source of exposure to arsenic is through
food, especially fish (3), and consumption of foods grown
in arsenic-contaminated soils (17). However, measurement of inorganic arsenic concentration rather than the
total arsenic concentrations should reduce confounding
effects of seafood ingestion, and in a previous study in
two Arizona mining towns, concentration of arsenic in
house-dust was not associated with urinary arsenic concentrations in adults (18). Because urine creatinine levels
were only available for 11 individuals from Ajo at baseline, our statistical power to detect pre- and post-intervention differences in creatinine-adjusted arsenic levels
was limited.
In conclusion, the arsenic-free drinking-water intervention resulted in only modest reductions in urinary
arsenic concentrations. The total inorganic urinary arsenic level was reduced by 21%, although analysis of creatinine-adjusted urinary and toenail arsenic failed to corroborate significant reduction in arsenic exposure. This
implies that there was probably greater use of tap-water
for food and beverage preparations than realized or reported and/or that other non-water sources of arsenic
were present. Evaluations of similar populations before
and after providing water-treatment systems, as contrasted
with bottled water, would provide a useful comparison.
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